Trang chủ › U tủy xương đa phát › Georgia › Atlanta
Thử nghiệm lâm sàng cho U tủy xương đa phát tại Atlanta, GA
42 nghiên cứu cho U tủy xương đa phát đang tìm kiếm người tham gia tại các cơ sở ở Atlanta và vùng lân cận (bán kính khoảng 30 dặm). Mở nghiên cứu để xem tiêu chí tham gia và cách liên hệ với đội ngũ nghiên cứu.
Văn bản nghiên cứu chính thức (Tiếng Anh)
Đang tuyển dụng cho một nghiên cứu? Đưa tin của bạn lên đầu trang này — $99 trong 30 ngày →
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Đang tuyểnGiai đoạn 3
- Emory University Hospital Midtown, Atlanta
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
Đang tuyểnGiai đoạn 1
- Winship Cancer Institute of Emory University, Atlanta
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
Đang tuyểnGiai đoạn 3
- Emory University - Winship Cancer Institute, Atlanta
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Đang tuyểnGiai đoạn 4
- Emory University, Atlanta
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Đang tuyểnGiai đoạn 3
- Emory University, Atlanta
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Đang tuyểnGiai đoạn 2
- Emory University Winship Cancer Institute, Atlanta
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Đang tuyểnGiai đoạn 1
- Emory Winchip Cancer Center, Atlanta
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Đang tuyểnGiai đoạn 2
- Winship Cancer Institute, Emory University, Atlanta
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Đang tuyểnGiai đoạn 1
- Winship Cancer Institute, Emory University, Atlanta
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Đang tuyểnGiai đoạn 1/2
- Research Site, Atlanta
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Đang tuyểnGiai đoạn 3
- Winship Cancer Institute, Emory University, Atlanta
Collection of Tissue Samples for Cancer Research
Đang tuyểnNghiên cứu quan sát
- Emory University, Atlanta
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Đang tuyểnGiai đoạn 1/2
- Emory University Hospital, Atlanta
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Đang tuyểnGiai đoạn 1/2
- Emory University Winship Cancer Center, Atlanta
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Đang tuyểnGiai đoạn 1
- The Winship Cancer Institute of Emory University, Atlanta
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
Đang tuyểnGiai đoạn 3
- Research Site, Atlanta
- Research Site, Atlanta
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Đang tuyểnGiai đoạn 1/2
- Winship Cancer Institute of Emory University /ID# 274830, Atlanta
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Đang tuyểnGiai đoạn 2/3
- Winship Cancer Institute of Emory University /ID# 277667, Atlanta
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
Đang tuyểnGiai đoạn 1/2
- Research Site, Atlanta
CAR T-cell Therapy in Patients With Renal Dysfunction
Đang tuyểnGiai đoạn 2
- Caitlin Guzowski, Atlanta
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Đang tuyểnGiai đoạn 1/2
- Research Site, Atlanta
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Đang tuyểnGiai đoạn 2
- Winship Cancer Institute of Emory University, Atlanta
- Northside Hospital, Atlanta
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Đang tuyểnGiai đoạn 2
- Emory University (Data Collection Only), Atlanta
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Đang tuyểnGiai đoạn 3
- Research Site, Atlanta
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Đang tuyểnGiai đoạn 3
- Emory University, Atlanta
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
Đang tuyểnGiai đoạn 1
- Winship Cancer Institute Emory University, Atlanta
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
Đang tuyểnGiai đoạn 1
- Research Site, Atlanta
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
Đang tuyểnGiai đoạn 1/2
- Emory University Hospital, Atlanta
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Đang tuyểnGiai đoạn 2
- Cancer Treatment Centers of America - Atlanta, Atlanta
- Emory University Winship Cancer Institute, Atlanta
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
Đang tuyểnGiai đoạn 1/2
- Winship Cancer Institute of Emory University, Atlanta
Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
Đang tuyểnGiai đoạn 2
- Emory University/Winship Cancer Institute, Atlanta
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Đang tuyểnGiai đoạn 1
- Emory University Hospital, Atlanta
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Đang tuyểnGiai đoạn 3
- Research Site, Atlanta
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
Đang tuyểnGiai đoạn 4
- Emory University Hospital/Winship Cancer Institute, Atlanta
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Đang tuyểnGiai đoạn 1
- Northside Hospital, Atlanta
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Đang tuyểnGiai đoạn 1/2
- Emory Winship Cancer Institute, Atlanta
Personalized Autologous Transplant for Multiple Myeloma
Đang tuyểnGiai đoạn 1
- Winship Cancer Institute of Emory University, Atlanta
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Đang tuyển
- Emory University Hospital/Winship Cancer Institute, Atlanta
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Đang tuyểnGiai đoạn 3
- GSK Investigational Site, Atlanta
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Đang tuyểnGiai đoạn 1
- Winship Cancer Institute, Atlanta
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Đang tuyểnGiai đoạn 1/2
- Emory University Hospital, Atlanta
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
Đang tuyểnGiai đoạn 1
- Northside Hospital, Atlanta
Thử nghiệm cho U tủy xương đa phát tại các thành phố khác
- New York City, NY59 nghiên cứu
- Boston, MA45 nghiên cứu
- Houston, TX39 nghiên cứu
- Durham, NC36 nghiên cứu
- Nashville, TN31 nghiên cứu
- Denver, CO26 nghiên cứu
- St. Louis, MO26 nghiên cứu
- Rochester, MN25 nghiên cứu
- Columbus, OH25 nghiên cứu
- Chicago, IL24 nghiên cứu
- Milwaukee, WI23 nghiên cứu
- Baldwin Park, CA23 nghiên cứu
Các nghiên cứu khác tại Atlanta
- Ung thư (mọi loại)49 nghiên cứu
- Ung thư phổi không tế bào nhỏ48 nghiên cứu
- Ung thư vú42 nghiên cứu
- Ung thư tuyến tiền liệt36 nghiên cứu
- Bạch cầu tủy cấp30 nghiên cứu
- Ung thư di căn29 nghiên cứu
- Ung thư buồng trứng29 nghiên cứu
- Ung thư đại trực tràng29 nghiên cứu
- Ung thư phổi28 nghiên cứu
- Béo phì26 nghiên cứu
- Rối loạn trầm cảm nặng24 nghiên cứu
- Suy tim23 nghiên cứu
Nguồn dữ liệu từ ClinicalTrials.gov, cập nhật ngày 15 thg 11, 2026. Mỗi nghiên cứu có tiêu chí riêng; đội ngũ nghiên cứu sẽ quyết định ai đủ điều kiện tham gia.